{"schema_version":"secwatch.filing_event.v1","accession":"0000883984-22-000029","form_type":"8-K","ticker":"ICUI","cik":"0000883984","company_name":"ICU MEDICAL INC/DE","filed_at":"2022-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:04:04.110492+00:00","generated_at":"2026-06-25T22:46:08.212214+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"ICU Medical Q1 revenue $543M, GAAP net loss $38.1M, adjusted EPS $1.82","bullets":["Revenue $543.1M, up 71% from $318.0M in Q1 2021.","GAAP net loss of $38.1M ($1.61 per diluted share) vs net income of $23.7M ($1.09) in Q1 2021.","Adjusted diluted EPS $1.82, up from $1.62; adjusted EBITDA $84.9M vs $57.8M.","GAAP gross margin declined to 31% from 35% in Q1 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0000883984-22-000029","json":"https://secwatch.observer/filing/0000883984-22-000029.json","markdown":"https://secwatch.observer/filing/0000883984-22-000029.md","text":"https://secwatch.observer/filing/0000883984-22-000029.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883984/000088398422000029/0000883984-22-000029-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883984/000088398422000029/icui-20220509.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T22:46:08.212214+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}